217 related articles for article (PubMed ID: 25134500)
1. Differential effects of dopamine D1 and D 2/3 receptor antagonism on motor responses.
Tran S; Nowicki M; Muraleetharan A; Gerlai R
Psychopharmacology (Berl); 2015 Feb; 232(4):795-806. PubMed ID: 25134500
[TBL] [Abstract][Full Text] [Related]
2. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
Neisewander JL; O'Dell LE; Redmond JC
Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
[TBL] [Abstract][Full Text] [Related]
3. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.
Scardochio T; Clarke PB
Psychopharmacology (Berl); 2013 Apr; 226(3):589-600. PubMed ID: 23192317
[TBL] [Abstract][Full Text] [Related]
5. Effects of dopamine receptor antagonists on the acquisition of ethanol-induced conditioned place preference in mice.
Pina MM; Cunningham CL
Psychopharmacology (Berl); 2014 Feb; 231(3):459-68. PubMed ID: 24005528
[TBL] [Abstract][Full Text] [Related]
6. D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice.
Rinaldi A; Mandillo S; Oliverio A; Mele A
Neuropsychopharmacology; 2007 Feb; 32(2):309-19. PubMed ID: 16900106
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D
Oliveri AN; Levin ED
Behav Brain Res; 2019 Jan; 356():250-256. PubMed ID: 30172631
[TBL] [Abstract][Full Text] [Related]
8. Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15.
Kiss B; Laszlovszky I; Horváth A; Némethy Z; Schmidt E; Bugovics G; Fazekas K; Gyertyán I; Agai-Csongor E; Domány G; Szombathelyi Z
Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):515-28. PubMed ID: 18551280
[TBL] [Abstract][Full Text] [Related]
9. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani A
J Psychopharmacol; 2003 Dec; 17(4):415-23. PubMed ID: 14870954
[TBL] [Abstract][Full Text] [Related]
10. Apomorphine-induced context-specific behavioural sensitization is prevented by the D1 antagonist SCH-23390 but potentiated and uncoupled from contextual cues by the D2 antagonist sulpiride.
Dias FR; Carey RJ; Carrera MP
Psychopharmacology (Berl); 2010 Apr; 209(2):137-51. PubMed ID: 20177884
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys.
Lee B; Groman S; London ED; Jentsch JD
Neuropsychopharmacology; 2007 Oct; 32(10):2125-34. PubMed ID: 17299511
[TBL] [Abstract][Full Text] [Related]
12. Functional interaction between dopamine D1 and D2 receptors in 'MPTP' monkeys.
Luquin MR; Guillén J; Martínez-Vila E; Laguna J; Martínez-Lage JM
Eur J Pharmacol; 1994 Mar; 253(3):215-24. PubMed ID: 7911084
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of acute administration of SCH-23390, a D₁ receptor antagonist, and of ethanol on swimming activity, anxiety-related responses, and neurochemistry of zebrafish.
Tran S; Nowicki M; Muraleetharan A; Chatterjee D; Gerlai R
Psychopharmacology (Berl); 2015 Oct; 232(20):3709-18. PubMed ID: 26210378
[TBL] [Abstract][Full Text] [Related]
14. Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects.
Peacock L; Hansen L; Mørkeberg F; Gerlach J
Neuropsychopharmacology; 1999 Jan; 20(1):35-43. PubMed ID: 9885783
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
[TBL] [Abstract][Full Text] [Related]
16. D1, but not D2, receptor blockade within the infralimbic and medial orbitofrontal cortex impairs cocaine seeking in a region-specific manner.
Cosme CV; Gutman AL; Worth WR; LaLumiere RT
Addict Biol; 2018 Jan; 23(1):16-27. PubMed ID: 27578356
[TBL] [Abstract][Full Text] [Related]
17. Dissociative effects of dorsomedial striatum D1 and D2 receptor antagonism in the regulation of anxiety and learned approach-avoidance conflict decision-making.
Nguyen D; Alushaj E; Erb S; Ito R
Neuropharmacology; 2019 Mar; 146():222-230. PubMed ID: 30508508
[TBL] [Abstract][Full Text] [Related]
18. Role of D1-like and D2-like dopamine receptors within the ventral tegmental area in stress-induced and drug priming-induced reinstatement of morphine seeking in rats.
Farahimanesh S; Moradi M; Nazari-Serenjeh F; Zarrabian S; Haghparast A
Behav Pharmacol; 2018 Aug; 29(5):426-436. PubMed ID: 29683809
[TBL] [Abstract][Full Text] [Related]
19. Isolation rearing impairs the reinforcing efficacy of intravenous cocaine or intra-accumbens d-amphetamine: impaired response to intra-accumbens D1 and D2/D3 dopamine receptor antagonists.
Phillips GD; Howes SR; Whitelaw RB; Robbins TW; Everitt BJ
Psychopharmacology (Berl); 1994 Jul; 115(3):419-29. PubMed ID: 7871084
[TBL] [Abstract][Full Text] [Related]
20. Involvement of D1 and D2 dopamine receptor in the retrieval processes in latent inhibition.
Diaz E; Medellín J; Sánchez N; Vargas JP; López JC
Psychopharmacology (Berl); 2015 Dec; 232(23):4337-46. PubMed ID: 26345345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
